Ledger.Open graph →
SEC Form D · filed July 13, 2018

ReShape Lifesciences Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN CLEMENTE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Robert A. Ingram · Durham, NCExec · DirectorDouglas Reed · Durham, NCDirectorChristy A. Shaffer · Durham, NCExecJohn C. Crumpler · Durham, NCDirectorClay B. Thorp · Durham, NCDirectorJames G. Perlin · New York, NYDirectorKarine G. Kisch · New York, NYExecDavid Goldstein · Mill Valley, CAExec · DirectorKevin Robl · Hawthorne, CADirectorAnand K. Chari · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗